A rare complication with Edwards Sapien: Aortic valve embolization in TAVI

Vascular ◽  
2014 ◽  
Vol 23 (1) ◽  
pp. 102-104 ◽  
Author(s):  
Hüseyin Ayhan ◽  
Tahir Durmaz ◽  
Telat Keleş ◽  
Hacı Ahmet Kasapkara ◽  
Kemal Eşref Erdoğan ◽  
...  

One of the problems is valve embolization at the time of transcatheter aortic valve implantation, which is a rare but serious complication. In this case, we have shown balloon expandable aortic valve embolization TAVI which is a rare complication and we managed with second valve without surgery. Although there is not enough experience in the literature, embolized valve was re-positioned in the arch aorta between truncus brachiocephalicus and left common carotid artery.

2015 ◽  
pp. 478-484 ◽  
Author(s):  
Zenon Huczek ◽  
Radosław Wilimski ◽  
Janusz Kochman ◽  
Piotr Szczudlik ◽  
Piotr Scisło ◽  
...  

2020 ◽  
Vol 30 (4) ◽  
pp. 605-612 ◽  
Author(s):  
Stephanie Voss ◽  
Johanna Schechtl ◽  
Christian Nöbauer ◽  
Sabine Bleiziffer ◽  
Rüdiger Lange

Abstract OBJECTIVES This study sought to determine the percentage of patients potentially eligible for implantation of the Sentinel™ Cerebral Protection System (Sentinel-CPS) during transcatheter aortic valve implantation (TAVI) and to identify the reasons for treatment exclusion. METHODS We retrospectively performed an analysis of pre-TAVI multislice computed tomography (MSCT) aortograms and data review of all patients undergoing a TAVI procedure in 2017 (n = 317). MSCT evaluation included the assessment of aortic arch anatomy and the vascular dimensions of the brachiocephalic and left common carotid artery. Data analysis focused on comorbid conditions, precluding 6-Fr sheath radial access and filter deployment due to history of previous artery interventions. RESULTS MSCT and data analysis showed Sentinel-CPS compatibility in 61.5% of patients (n = 195). Sentinel-CPS would have been contraindicated in 38.5% (n = 122) due to one or more of the following: (i) measured diameters of the filter-landing zones <9 or >15 mm in the brachiocephalic artery and <6.5 or >10 mm in the left common carotid artery (n = 116; 88 with carotid dimensions too small); (ii) significant subclavian artery stenosis (n = 4) or an aberrant subclavian artery (n = 3) precluding Sentinel-CPS implantation and (iii) clinical characteristics including hypersensitivity to nickel–titanium (n = 1), radial artery occlusion (n = 1) or previous left common carotid artery interventions (n = 5). CONCLUSIONS MSCT and clinical data supported Sentinel-CPS compatibility in 61.5% of patients. The most common reason for treatment exclusion was inappropriate diameter within the target landing zone of the left carotid artery. Future device development should address this limitation.


Sign in / Sign up

Export Citation Format

Share Document